Legal status · Canada
Is Cartalax legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Cartalax is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
Cartalax in Canada at a glance
| Classification | Not approved |
|---|---|
| Note | No Health Canada product licence located under this name. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 0 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Cartalax profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Cartalax is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Cartalax is
A three amino acid peptide studied almost entirely in cell culture by the group that developed it. The only human claim is a sentence in a 2023 review saying it was given orally to older osteoarthritis patients; no primary report of that human use has been located.
Cartalax is Ala-Glu-Asp, written AED, one of a family of ultrashort peptides designed at the St. Petersburg Institute of Bioregulation and Gerontology and assigned to cartilage.
Mechanism: Proposed as epigenetic regulation by an ultrashort peptide that enters the cell and interacts with DNA and histones to shift transcription. In chondrocyte work AED is reported to normalise a senescence pattern characterised by raised p16, p21, p53, TNF-alpha and IL-1-alpha and lowered Sirt1.
Regulatory history: Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Cartalax at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Cartalax in other countries
Frequently asked questions
Is Cartalax legal in Canada?
No. Cartalax is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: No Health Canada product licence located under this name.
Can I buy Cartalax in Canada?
No approved product exists to buy. In Canada Cartalax is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No Health Canada product licence located under this name.
Is Cartalax Health Canada approved?
No. In Canada Cartalax is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor.. On the evidence, no human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Cartalax live on its compound profile.
Cartalax profileThis page is general information about the regulatory status of Cartalax in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.